See Full Document Text
NOT OF STANDARD QUALITY ALERT FOR THE MONTH OF DECEMBER– 2024
As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of
Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make
stakeholders aware about the NSQ batches identified in the market.
B. State Laboratories
S.No Product/Drug Batch No. Manufact Expiry Manufactured By NSQ Result Reported by State
Name uring Date Laboratory
Date
1. Divalproex 2406031 06/2024 05/2026 Biodeal Uniformity of DTL Srinagar (J&K)
Extended Pharmaceuticals Ltd Weights & MDTL Kathua
Release Tablets Vill Saini (J&K)
IP MajraNalagarhRopar
(JKMSCL Road , Nalagarh -
Hospital Supply 174101 , Distt. Solan
not for sale) (H.P) India
2. Divalproex 2407185 07/2024 06/2026 Biodeal Uniformity of DTL Srinagar (J&K)
Extended Pharmaceuticals Ltd Weights
Release Tablets Vill Saini
IP MajraNalagarhRopar
(JKMSCL Road , Nalagarh -
Hospital Supply 174101 , Distt. Solan
not for sale) (H.P) India
3. Cefpodoxime CT3096 09/2023 08/2025 Bharat Parenterals Assay of CFDL Jammu (J&K)
Tablets IP 200 Ltd Survey No. 144-A, Cefpodoxime
mg (Jan Jarod-SamlayaRoad
Aushadhi) ,Vill. Haripura , Tal.
Savil Dist. Vadodara -
391520 Gujarat India
4. DEXTROMETH AST- Aug-23 Jul-25 M/s.AASSK On visual inspection Puducherry
ORPHAN 23303 Pharmaceuticals Pvt. dark spots are
HYDROBROMI Ltd. Plot No.9, S.no found on tablet
DE 243/2, surface.CappingandPHENYLEPHRI Dr.AmbedhkarStreet, lamination defects
NE Kozhumanivakkam, are found. Some
HYDROCHLOR Mangadu, Chennai- t a b le t s were brittle
IDE & 600 122 on opening from the
CHLORPHENIR strip - NSQ
AMINE
MALEATE
TABLETS
(Expal)
5. BETAHISTINE CT242502 May-24 Apr-26 M/s CMG BIOTECH On the received Puducherry
DIHYDROCHL 84B PVT. LTS (Unit-II), sample presence of
ORIDE Plot No. 58, PhaseIII, spots were
TABLETS IP Industrial Area, observed which
(CGHEST-8) Sansarpur Terrace, should not be
Tehsil Jaswan, present As per DCC
Distt.Kangra, HP- Guidelines on Not
176501 Of Standard Quality
(NSQ) Drugs
Approved in 1993
(Annexure A)
Tablets vide serial
No.(i) Presence of
Spot/discolouration
6. METFORMIN 4O30069 Feb-24 Jan-27 M/s.Cipla Ltd., Ropar Does not comply Puducherry
HYDROCHLOR Road, Nalagarh, Dist. with respect to the
IDE TABLETS Solan (H.P)-174 101 Assay as per IP
IP (OKAMET- specification
500)
7. PANTOPRAZO WAM2401 May-24 Apr-26 M/s Admed Pharma Does not comply Puducherry
LE GASTRO- 1 Pvt Ltd., Plot No 87, with respect to the
RESISTANT HPSIDC, Industrial Disintegration test
TABLETS IP Area, Badddi, as per IP
40mg DisttSolan HP- 173 specification
(Pentowok) 205
8. ZINC TH241106 Aug-24 Jul-26 M/s Orchid On the received Puducherry
SULPHATE MedlifePvt. ltd., sample chipping
DISPERSIBLE (WHO GMP & GLP and rough surface
TABLETS IP certified company) d e f e cts were20mg (CARE Vill.Kaundi,P.O observed, which
ZINC) Thane, s h o u l d not be
Khasra No. 646/513, present As per DCC
Tehsil Baddi, Dist. Guidelines on Not
Solan (H.P)- Of Standard Quality
173 205. (NSQ) Drugs
Approved in 1993
(Annexure A)
Tablets vide serial
No.(V) and (VII)
respectively
9. CEFIXIME AND T925 Sep-23 Aug-25 M/s. Swiss Biotech On the received Puducherry
LACTIC ACID Parentrals., Kewat sample presence of
BACILLUS No. 1138,VPO - spots/discoloration
TABLETS (CFI- Kachhwa, Karnal- observed which
200) 132001 (Haryana) should not be
present As per DCC
Guidelines on Not
Of Standard Quality
(NSQ) Drugs
Approved in 1993
(Annexure A)
Tablets vide serial
No.(i) Presence of
Spot/discoloration
10. METFORMIN G0374057 Jun-24 May-27 M/s.Franco-Indian Does not comply Puducherry
TABLETS IP Pharmaceuticals Pvt with respect to the
500 mg Ltd, 20, DR. E. Moses Assay as per IP
(GLYCIPHAGE) Road, Mumbai-400 specification
011
11. Ceaxil -500 BT-227375 01/2024. 12/2025. Dr Edwin Medilabs White coloured, State Lab,
Tablets, Pvt Ltd Plot No.B-29, elongated, biconvex Drugs Control
Cefuroxime Industrial Area, Focal tablets with score Laboratory,
Axetil Tablets IP Point, Chanalon, on one side, and Telangana.
Kurali, SAS Nagar- plain on other side,
140103(Pb) PUNJAB 10 out of 50 tablets
have brown-
coloured spots onthe entire surface.
Hence, the tablets
failed the test for
Description of
tablets.
12. Jakclav-625 BPT-3002 02/2024. 01/2026. Geenac Pharma Plot The sample Does State Lab,
Tablets, No: 582, Raipur, not meet the Drugs Control
Amoxicillin and Bhagwanpur, Specifications wrt. Laboratory,
Potassium Roorkee, Identification test - Telangana.
Clavulanate Uttarakhand-247667. Negative, Assay- Nil
Tablets UTTARAKHAND A s p e r I P u / s . 1 7 B
. o f D r u g s a n d
Mrkt By: Cosmetics Act
WellnowHelathcare, 1940. the Sample
Kanal Industrial deemed to be
Estate, Road No. 6, SPURIOUS and
Borivali East, Misbranded.
Mumbai-400066.
13. Jikcef-LB BPT-3005 02/2024. 01/2026. GeenacPharma Plot S t a t e L a b ,
Tablets, No: 582, Raipur, The sample does Drugs Control
Cefixime and Bhagwanpur, not meets the Laboratory,
Lactic Acid Roorkee, Specifications with Telangana.
Bacillus Tablets Uttarakhand-247667. respect to
UTTARAKHAND I d e n t i f i c a t io n t e s t - N i l
. A s s a y - N i l
Mrkt By: As per STP u/s.
WellnowHelathcare, 17B of Drugs and
Kanal Industrial Cosmetics Act
Estate, Road No. 6, 1940. The Sample
BorivaliEast, Mumbai- deemed to be
400066. SPURIOUS.
14. Jikcf-AZ BPT-3001 02/2024. 01/2026. Geenac Pharma Plot S t a t e L a b ,
Tablets, No: 582, Raipur, The sample does Drugs Control
Cefixime and Bhagwanpur, not meets the Laboratory,
Azitromycin Roorkee, Specifications with Telangana.
Tablets Uttarakhand-247667. respect to
UTTARAKHAND I d e n t i f i c a t io n t e s t - N i l
. A s s a y - N i lMrkt By: As per STP u/s.
WellnowHelath care, 17B of Drugs and
Kanal Industrial Cosmetics Act
Estate, Road No. 6, 1940. The Sample
Borivali East, deemed to be
Mumbai-400066. SPURIOUS.
15. Vithrocin AZ/L/01/40 08/2024. 07/2026. Vital Therapeutics & As sample failed State Lab,
Suspension, 09 Formulations Pvt.Ltd . with respect to test Drugs Control
Azithromycin Plot No. 47b/2, in pH as per IP Laboratory,
Oral Phase-1, IDA, further product is Telangana.
Suspension Cherlapally, Medchal- MISBRANDED
Malkajgiri District -
500051, Telangana,
INDIA. Telangana
16. Pantacea 40 PNTC3007 11/2023. 10/2025. Windlas Biotech S ta t e L a b ,
Tablets and Limited Plant-2, The sample Does Drugs Control
Pantoprazole Khasra No. 141 to not complies in Laboratory,
Gastro 143 & 145, respect of Telangana.
Resistant MohabewalaIndl.area, Dissolution Test as
Tablets IP 40mg Dehradun – 248110 per IP.
(U.K.)
UTTARAKHAND
Mrkt By: Panacea Life
Sciences Limited,
DCM Building,
OffceNo.5, Seventh
floor, 16 Barakhamba
Road, Connauught
place, New Delhi-
110001.
17. Pantoprazole P01824 08/2024. 07/2026. Spansules S ta t e L a b ,
Sodium formulation India Pvt The sample Does Drugs Control
Tabletes IP Ltd Sy. No. 172, not comply in Laboratory,
40mg Plot.No.154/A4 IDA respect of Telangana.
Bollaram (V), Dissolution Test as
Jinnaram (M), per IP.
Sangareddy (D),
HyderabadTelangana
18. Metoprolol URDT0654 03/23 02/25 Unicure India Ltd., It fails the test Drugs Testing
Succinate Plot No. 46(B)/49B ‘Assay’ as per IP Laboratory
Prolonged Village Raipur, standards Thiruvananthapuram
Release Tablets Bhagwanpur [Amendment List -
IP ,RoorkeeDist, 05 to IP 2022]
Haridwar,
Uttarakhand
19. Metoprolol URDT0653 03/23 02/25 Unicure India Ltd., It fails the test Drugs Testing
Succinate Plot No. 46(B)/49B ‘Assay’ as per IP Laboratory
Prolonged Village Raipur, standards Thiruvananthapuram
Release Tablets Bhagwanpur [Amendment List -
IP ,RoorkeeDist, 05 to IP 2022]
Haridwar,
Uttarakhand
20. Metoprolol URDT0652 03/23 02/25 Unicure India Ltd., It fails the test Drugs Testing
Succinate Plot No. 46(B)/49B ‘Assay’ as per IP Laboratory
Prolonged Village Raipur, standards Thiruvananthapuram
Release Tablets Bhagwanpur [Amendment List -
IP ,RoorkeeDist, 05 to IP 2022]
Haridwar,
Uttarakhand
21. Losartan HLOA09 11/23 10/25 Hindusthan It fails the test Drugs Testing
Potassium Antibiotics Ltd, At 11, ‘Dissolution’ as per Laboratory
Tablets IP 50 W.E.A, Faridabad - IP as specified in Thiruvananthapuram
mg 121 001, Haryana the Laboratory
Protocol
22. Amoxymoon VT 241704 10/24 03/26 VADSP It fails the tests Drugs Testing
CV-625 Pharmaceuticals, Plot ‘Assay’ and Laboratory
[Amoxycillin and No.124, EPIP, ‘Dissolution’ for Thiruvananthapuram
Potassium Indl.Area, Phase-1, Clavulanic Acid as
Clavulanate Jharmajri, Baddi (H.P) per IP, as specified
Tablets IP] 174 103 in the Laboratory
Protocol .
23. Balarishtam 107 09/24 10 Yrs. Alappat Pharma, It fails the test Total Drugs Testing
Form Kollam-691503 Solids and Specific Laboratory
packing Gravity as per API Thiruvananthapuram
24. Metformin D2164/24- Kerala Medical It fails the test Drugs TestingHydrochloride 25 Services Corporation microbial Laboratory
Sustained Ltd, Thycaud P.O, contamination in Thiruvananthapuram
Release Tab IP Thiruvananthapuram- Non-sterile products
500 mg 14 and Descriptive part
for tablets as per IP
25. Paracetamol D2370/24- Kerala Medical It fails the test Drugs Testing
Tab IP 500 mg. 25 Services Corporation ‘Dissolution’ as per Laboratory
Ltd, Thycaud P.O, IP Thiruvananthapuram
Thiruvananthapuram-
14
26. CIPRODAC 500 A N24014 Jan-24 Dec-26 Cadila The Sample does State Drugs Testing
(Ciprofloxacin Pharmaceuticals not conform to Laboratory, Agartala,
Tablets IP Limited, 1389, Dholka standard in respect Tripura.
500mg) – 382225, Dist: of the test
Ahmedabad, At: A-1, "Dissolution"
Ratan Industrial Area, performed
Harsuliya, Jaipur.
C/o. M/S. Anon
Pharmaceutical,
Jaipur. Mfg. Lic. No.:
RAJ/JPR/2718.
27. Metoheal XL 25 T24D800A D/M: D/E: M/s. Bajaj Test for Dissolution” Karnataka
(Metoprolol Apr/2024 Mar/2026 Formulation, Khasra & content of
Succinate No.161, Village- Metoprolol
Extended LakeshwaryBhagwan Succinate in the
release Tablets pur, RoorkeeDistt: Assay
U.S.P) Haridwar (UK)
28. Panik-D Tablets KPT24K08 D/M:02/2 D/E:01/202 M/s. Kaizen test for Karnataka
(Pantoprazole A 024 6 Pharmaceuticals, Vill. Disintegration
Sodium Katha, Baddi-173205
&Domperidone Distt. Solan (H.P)
Tablets)
29. Fercobate-XT 240603 D/M: D/E: M/s. Folic Acid in the Karnataka
Suspension Jun/2024 Nov/2025 ShinestarPharma, Assay and
(Ferrous Begapali Road, Misbranded
Ascorbate& SIPOCT-1, Hosur-
Folic acid 635126 (T.N)
Suspension)30. CefpodoximePr KCT- D/M:03/2 D/E:02/202 M/s. Knox Life Test for Uniformity Karnataka
oxetil 403002 024 6 Sciences, Vill. of Dispersion
Dispersible Gullarwala, Sai Road,
Tablets (Qupod- Baddi, Distt. Solan
200 Tablets) (H.P)
31. Calcium MWT2311 D/M: D/E: M/s. MedworPharma, Test for Dissolution Karnataka
Carbonate & 80 Jan/2024 Dec/2025 140 EPIP, Phase-II, for Calcium, Assay
Vitamin D3 Thana, Baddi 173205 for Vitamin D3” and
Tablets with respect to
(Calcovit D3 “Description
Tablets)
32. Ranitidine AV3082 D/M: D/E: M/s. Alpa Test for Sterility Karnataka
Hydrochloride 02/2023 01/2025 Laboratories Ltd.,
Injection I.P 33/2 A.B. Road,
Pigdamber-453 446,
Indore (M.P)
33. Cipex-500 MUTAD23 D/M: D/E: M/s. Maxtar Bio- Test for Dissolution Karnataka
(Ciprofloxacin 01 Jun/2023 May/2026 Genics, K.No.705, only
Tabets I.P) Nalagarh Road,
MalkuMajra, Baddi-
173205 (H.P)
34. Terbicharge 250 NT-4303 D/M: D/E: M/s. Neptune Life Test for Dissolution Karnataka
mg 06/2023 05/2025 Sciences Pvt. Ltd., only
(TerbinafineHyd 100-B, EPIP, Phase-
rochloride II, Thana, Baddi-
Tablets IP) 173205 (H.P)
35. Levocetirizin 2405097 D/M: D/E: M/s. Aban Test for Dissolution Karnataka
Hydrochloride May/2024 Apr/2026 Pharmaceuticals, Plot of Levocetirizine
&Montelukast No. 1018, Kerala, Hydrochloride and
Sodium Tablets G.I.D.C., Bavla, Dist. Montelukast
IP (Montefirst- Ahmedabad-382220
LC)
36. Paracetamol PCT24135 D/M: D/E: M/s. Test for Dissolution Karnataka
Tablets IP 650 06/2024 05/2026 VivekPharmachem
mg (India) Ltd., NH-8,
Chimanpura, Amer,
Jaipur-303102
37. Aluminium, C21A1330 D/M: D/E: M/s. Concept Description only KarnatakaMagnesium 03 06/2023 05/2026 Pharmaceuticals Ltd.,
&Simethicone A-28/3, MIDC,
Oral Chikalthana,
Suspension I.P Aurangabad-431006
38. ITRACHARGE NC-0805 D/M: D/E: M/s. Neptune Life Dissolution Test Karnataka
200 06/2023 05/2025 Sciences Pvt. Ltd., only
(Itraconazole 100-B, EPIP, Phase-
Capsules BP) II, Thana, Baddi-
173205 (H.P)
39. Ondansetron A24AM130 04/2024 03/2026 Skymap sample does not King Institute of
Injection IP-2ml Pharamceuticals Pvt. conform to Preventive Medicine
Ltd, B-2 Dev Bhoomi requirement for & Research, Guindy,
Industrial Estate, assay and related Chennai-32
Puhana Iqbalpur substances
Road, Roorkee - 247
667
40. Cipladine CH040103 03/2024 02/2026 HSN International, At Sample does not Drugs Testing
Multipurpose Plot No.54-55, Sector conform to USP Laboratory, Chennai -
Antiseptic Skin 6A, I.I.E, Sidcul, specification for 6
Ointment Haridwar, povidone-Iodine
Uttarakhand,249403. Ointment with
respect to content
of available Iodine
in povidone Iodine.
41. Povidone- VG24025 04/2024 03/2026 Microwin Labs PVt Sample does not Drugs Testing
Iodine Ointment Ltd, Plot No.363, conform to USP Laboratory, Madurai -
USP Industrial Focal Point, Spcification for 19.
Phase-9, Mohali- povidine-IODINE
160062. Ointment with
respect to the
content of Avaible
Iodine in povidone
Iodine.
42. Atorvastatin HTN414D 04/2024 03/2026 Himalaya Meditek Sample does not Drugs Testing
Calcium Tablets Pvt. Ltd, Plot No. 35 & conform to IP Laboratory, Chennai -
IP 10mg 36, Pharmacity, Specification for 6
Selaqui, Industrial Atorvastatin
Area, Dehradun - 248 Calcium Tablets197 with respect to
Dissolution
43. Atorvastatin HTN405D 04/2024 03/2026 Himalaya Meditek Sample does not Drugs Testing
Calcium Tablets Pvt. Ltd, Plot No. 35 & conform to IP Laboratory, Chennai -
IP 10mg 36, Pharmacity, Specification for 6
Selaqui, Industrial Atorvastatin
Area, Dehradun - 248 Calcium Tablets
197 with respect to
Dissolution
44. Ciprofloxacin HTN1126L 11/2023 10/2025 Himalaya Meditek Sample does not Drugs Testing
Hydrochloride Pvt. Ltd, Plot No. 35 & conform to IP Laboratory, Chennai -
Tablets IP 36, Pharmacity, specification for 6
500mg Selaqui, Industrial ciprofloxacin tablets
Area, Dehradun - 248 with respect to
197 Dissolution
45. Amlod-At DT240289 02/2024 01/2026 Daeiou Sample does not Drugs Testing
Pharmaceutical (P) conform to IP Laboratory, Chennai -
Ltd, R.S.No.158, Specification for 6
Puducherry - Amlodipine and
Villupuram Main Atenolol Tablets
Road, Villianur, with respect to
Puducherry, 605110. Dissolution for
Amlodipine and to
the Content of
Amlodipine in
Amlodipine in
Amlidipine Besylate.
46. Glimepiride PGG24- 06/2024 05/2026 Pondchy Sample does not Drugs Testing
Tablets IP 1mg 002 Pharmaceuticals, conform to IP Laboratory, Chennai -
R.S.No.218/4, 218/5, specification for 6
Odiaampet, Manaveli Glimepiride Tablets
Road, Villianur with respect to
Commune, Dissolution.
Puducherry, 605110.
47. Snikuf 4 RZAB01 05/2023 04/2025 Akums Drugs & Sample does not Drugs Testing
Pharmaceuticals Ltd, conform to label Laboratory, Chennai -
22, Sector-6A, I.I.E, claim with respect 6
Sidcul. Ranipur, to the content ofHaridwar-249403, Terbutaline
Uttrakhand. Sulphate.
48. Trubery LS Z-23388 09/2023 08/2025 CSD Lifesciences, Sample does not Drugs Testing
Village Malkumajra, conform to Label Laboratory, Chennai -
Morepen Road, with respect to the 6
Baddi, Distt, Solan, content of
(H.P). 173205. Levosalbutamol in
Levosalbutamol
sulphate.
49. Sucrazum-O ALL-899 08/2023 07/2025 Access Life Science, Sample does not Drugs Testing
Suspension Khasra No.551/3, conform to Label Laboratory, Chennai -
Village Taksal, claim with respect 6
Parwanoo, Distt, to the content of
Solan (HP), 173220. Oxetacaine.
50. Rosuvastatin, MC240184 02/2024 01/2026 Mascot Health Series Sample does not Drugs Testing
Aspirin & Pvt Ltd., Plot No. 79, conform to Label Laboratory, Chennai -
Clopidogrel 80 Sec-6A, IIE, claim with respect 6
Capsules Sidcul, Haridwar- 249 to the content of
(20mg/75mg/75 403 Aspirin and to
mg) Schedule V of
Drugs and
Cosmetics Act, with
respect to free
Salicylic Acid.
51. Metoclopramide 24DQC64 03/2024 02/2026 SVP Life Sciences, sample does not King Institute of
HCL Injection C/10-1, Sara conform to the Preventive Medicine
I.P-2ml Industrial Estate, requirement for & Research, Guindy,
Selaqui, Dehradun Assay of Chennai-32
Metoclopramide
52. Metoclopramide HLI405D 04/2024 03/2026 Himalaya Meditek sample does not King Institute of
HCL Injection Pvt. Ltd, Plot No. 35 & conform to the Preventive Medicine
I.P-2ml 36, Pharmacity, requirement for & Research, Guindy,
Selaqui, Industrial Assay of Chennai-32
Area, Dehradun - 248 Metoclopramide
197
53. Amitriptyline TA24159 04/2024 03/2026 Saintlife Sample does not Drugs Testing
Tablets IP 25mg Pharmaceuticals Ltd, conform to IP Laboratory, Chennai -
323, Central Hope specification for 6Town, Industrial Area, tablets with respect
Selaqui, Dehradun - to Definition.
248 011,
Uttarakhand, India
54. Megapure-TZ IU 23L-162 09/2023 08/2025 Prispag Pharma, Sample does not Drugs Testing
suspension Roomi, Jagraon - conform to label Laboratory, Chennai -
142030. claim with respect 6
to the content of
Ciprofloxacin in
Ciprofloxacin
Hydrochloride and
Tinidazole.
55. Octenidine PPKAC84 05/2023 04/2026 Pure & Cure Sample does not Drugs Testing
Dihydrochlordie Healthcare Pvt Ltd, (A conform to label Laboratory, Madurai -
Gel Subsidiary of Akums claim with respect 19.
Drugs & to the content of
Pharmaceuticals Ltd,) Octenidine
Plot No.26A,27-30, Dihydrochloride.
Sector - 8A,IIE,
Sidcul, Haridwar-
249403. Uttarakhand.
56. Dexamethasone TA24036 01/2024 12/2025 Saintlife Sample does not Drugs Testing
Tablets IP Pharmaceuticals Ltd, conform to IP Laboratory, Chennai -
0.5mg 323, Central Hope Specification for 6
Town, Industrial Area, Dexamethasone
Selaqui, Dehradun - Tablets with respect
248 011, to the content of
Uttarakhand, India Dexamethasone.
57. Dexamethasone TA24035 01/2024 12/2025 Saintlife Sample does not Drugs Testing
Tablets IP Pharmaceuticals Ltd, conform to IP Laboratory, Chennai -
0.5mg 323, Central Hope Specification for 6
Town, Industrial Area, Dexamethasone
Selaqui, Dehradun - Tablets with respect
248 011, to the content of
Uttarakhand, India Dexamthasone.
58. Peedon P2409 05/2024 04/2026 Sharing formulations Sample does not Drugs Testing
Pvt Ltd, Plot conform to label Laboratory, Chennai -
No.41,G.I.D.C, claim with respect 6Waghodia, Vadodara. to the content of
391760. Available Iodine in
Povidone-Iodine.
59. Esilac Soluion ZBL-1154 12/2023 11/2025 Zoic Biotech Pvt Ltd, Sample does not Drugs Testing
Plot No.C-15, Focal conform to USP Laboratory, Chennai -
Point, Ind. Area, Specification for 6
Chanalon, Mohali, Lactulose Solution
(Punjab), 140103. with respect to the
Content of
Lactulose in
Lactulose
Concentrate.
60. Amoxycillin PGA24- 03/2024 02/2026 Pondchy Sample does not Drugs Testing
Dispersible 002 Pharmaceuticals, conform to IP Laboratory, Chennai -
Tablets IP 125 R.S.No.218/4, 218/5, Specification for 6
mg Odiaampet, Manaveli Dispersible Tablets
Road, Villianur with respect to
Commune, uniformity of
Puducherry, 605110. Dispersion and
Disintegration
61. Orsiclop-A75 NTT24103 03/2024 02/2026 Nanoceut Sample does not Drugs Testing
6 Therapeutics Pvt Ltd, conform to IP Laboratory, Chennai -
R.S.No. 104/19A, specification for 6
E.V.R.Street, Clopidogrel and
Sedarapet, Aspirin Tablets with
Puducherry, 605111 respect to
Dissolution (
Clopidogrel and
Aspirin), Free
Salicylic Acid
(Related substance
for Aspirin) and to
the content of
ASpirin
62. Iron Sucrose PGY23118 08/2023 07/2025 Affy Parenterals, Vill. Sample does not King Institute of
Injection USP- Gullerwala, P.O. conform to Preventive Medicine
5ML Baddi, Distt. Solan - requirement for & Research,
173 205 (H.P) assay for iron. Guindy, Chennai-3263. Justkof-LS UF267408 01/2024 12/2025 Ultra Drugs sample does not Drugs Testing
2F Formultations Pvt Ltd, conform to Label Laboratory, Madurai -
Plot No.338/278, Vill. claim with respect 19.
Manakpur, to the content of
Lodhimajra, Tehsil- Ambroxol
Baddi, Distt. Solan Hydrochloride.
(HP)-173205.
64. Gabacure Gel HUAA46 06/2024 11/2025 Akums Druges & Sample does not Drugs Testing
Pharmaceuticals Ltd. conform to Label Laboratory, Madurai -
47,48,Sector-6A, claim with respect 19.
I.I.E., SIDCUL,, to the content of
Haridwar-249 403, Gobapentin.
Uttarakhand.
65. Dexamethasone FDDTI-004 02/2024 01/2026 Laborate Sample does not King Institute of
Injection IP-2ml Pharmaceuticals India conform to Preventive Medicine
Ltd, 51 Indl. Area, requirement for & Research,
Paonta Sahib (HP). Assay. Guindy, Chennai-32
66. Ondansetron 320D2401 04/2024 03/2026 SSM Formulations Sample does not Drugs Testing
Tablets IP 4 mg Private Limited, conform to IP Laboratory, Chennai -
Survey No. 11/1, Specification for 6
Mouza Ashti (Rith), Ondansetron
Hinganghar (M.H), Tablets with respect
442301 to Dissolution.
67. O Mak-200 VMWT240 06/2024 03/2026 Vertex Pharma Sample does not Drugs Testing
7 Chemicals, Plot conform to IP Laboratory, Madurai -
No.60-A,61-A, Specification of 19.
PIPDIC Electronic Ofloxacin Tablets
Park, Tirubhuvanai, with respect to the
Puducheryy-605107. content of
Ofloxacin.
68. Retrazith-250 WT3927F 03/2024 02/2026 Saphnix Life Sample does not Drugs Testing
Sciences, Village- conform to IP Laboratory, Chennai -
Barotiwala, Paonta specification for 6
Sahib,Distt, Siramour, Azithromycin
Himachal Pradesh- Tablets with respect
173025 to Dissolution and
to the Content of
AnhydrousAzithromycin
Dihydrate.
69. Surgi Spirit SS-084032 08/2024 07/2026 Transflex, Hawahar Sample does not Drugs Testing
Nagar, Ranipur conform IP Laboratory, Chennai -
(C.G),492001. Specifciation for 6
Surgical Spirit with
respect to weight
per ml.
70. Brokuf-DM CBL- 02/2024 01/2026 C.B.Healthcare, Sample does not Drugs Testing
0024/24 Village Messa Tibba, conform to Label Laboratory, Chennai -
Tehsil Nalagarh, Distt, claim with respect 6
Solan (H.P),174101. to the content of
phenylephrine
Hydrochloride.
71. Tamcof-Ls AGL23022 03/2024 02/2026 Asterisk Healthcare, Sample does not Drugs Testing
Syrup 1C V.P.O Bathri, Thesil conform to Label Laboratory, Chennai -
Haroli, Distt. Una claim with respect 6
(H.P),174301. to the content of
Ambroxol
Hydrochloride
72. Cadcof-Lx DLS2378 06/2024 05/2026 Dhwanilife Care Pvt Sample does not Drugs Testing
Syrup Ltd, Plot No.C-20/2, conform to Label Laboratory, Chennai -
(C-39) & C-20/3, (C- Claim with respect 6
40), Arvind Mega to the content of
Parek, Village- Levosalbutamol in
Chachravadi Vasna, Levosalbutamol
Ahmedabad, Gujarat- Sulphate, Ambroxol
382213. Hydrochloride and
Guaiphenesin.
73. Co-Trimoxazole MT404 01/2024 12/2026 Maxwell Lifescience Sample does not Drugs Testing
Tablets IP Pvt Ltd, T-53 & T-81, conform to IP Laboratory, Chennai -
480mg M.I.D.C, Tarapur, Specification for Co- 6
Boisar, Dist, Palghar, Trimoxazole Tablets
401506. with respect to
Dissolution for
Sulphamethoxazole
74. Cipladine CHO40018 01/2024 12/2025 HSN International, At Sample does not Drugs Testing
point No.54-55, conform to USP Laboratory, Madurai -Sector 6A, I.IE, Sidcul Specification for 19.
Haridwar, Povidone- Iodine
(Uttarakhand), Ointment with
249403 respect to the
content of Avaible
Iodine in Povidone
Iodine,
75. Cipladine CHO40020 01/2024 12/2025 HSN International, At Sample does not Drugs Testing
Ointment point No.54-55, conform to USP Laboratory, Madurai -
Sector 6A, I.IE, Sidcul Specification for 19.
Haridwar, Povidone-Iodine
(Uttarakhand), Ointment with
249403 respect to the
content of Avaible
Iodine in Povidone
Iodine.
76. Atovaris-F DEMT- 04/2024 03/2026 Dr.Edwin Medilabs Sample does not Drugs Testing
240124B Pvt Ltd, Plot No.B-29, conform to IP Laboratory, Madurai -
Industrial Area, Focal Specification with 19.
Point, Chanalon, respect to
Kurali, SAS Nagar- Uniformity of
140103(pb). Weight.
77. Capiwash FL-050B 08/2023 07/2025 Forgo Sample does not Drugs Testing
Mouthwah Pharmaceuticals, 27, conform to IP Laboratory, Madurai -
Dic Ind Area, Specification for 19.
Barotiwala, the Baddi, Chlorhexidine
Distt, Solan (H.P)- Mouthwash IP with
174103 respect to the
content of
Chlorhexidine
Gluconate in
Chlorhexidine
Gluconate Solution.
78. Povidone- VG23017 11/2023 10/2025 Microwin Labs PVt Sample does not Drugs Testing
Iodine Ointment Ltd, Plot No.363, conform to USP Laboratory, Madurai -
USP Industrial Focal Point, Specification for 19.
Phase-9, Mohali- Povidone - Iodine
160062. Ointment withrespect to the
content of Avaible
Iodine in Povidone
Iodine.
79. Flucent Pour-on PB-105/12 12/2023 11/2025 Indo Gulf Sample does not Drugs Testing
Solution Pharmaceuticals, 5.4 conform to Label Laboratory, Madurai -
K.M, Meerut Road, claim with respect 19.
Muzaffarnagar (U.P) to Identification and
Content of
Flumethrin.
80. Betamethasone B06 05/2024 04/2026 Syndicate Pharma, Sample does not Drugs Testing
Valerate 185/B, 185/B-1, 187/A conform to IP Laboratory, Madurai -
Ointment IP & 188, sector -F, specification for 19.
01% w/w Sanwer Road, Indore- Betamethasone
452015. Valerate Ointment
with respect to the
content of
Betamethasone in
Betamethasone
Valerate.
81. Clobium TYOL-047 07/2024 06/2026 Tanmed Pharma (I) Sample does not Drugs Testing
Suspension. Pvt Ltd, No.1/429, conform to BP Laboratory, Chennai-
Clobazam Oral Multi Industrial Nagar, specification for 6
Suspension BP Gerugambakkam, Clobazam Oral
5mg Chennai-600128 Suspension with
respect to
Dissolution and to
the content of
Clobazam
82. Chlorpheniramin IAL77/23 12/2023 11/2025 Anra Sample does not King Institute of
e Maleate Pharamaceuticals Pvt conform to the Preventive Medicine
Injection Ltd, Madurai-Melur requirement for & Research,
Road, Vellaripati, Assay for Guindy, Chennai-32
Madurai-625122 Chlorpheniramine
83. Chro-B Gold DCBGT- 09/2024 02/2026 Kniss Laboratories Sample does not Drugs Testing
2402 (P) Ltd, Plot No. 9, conform to label Laboratory, Chennai -
Multe Industrial claim with respect 6
Estate, to the content ofGerugambakkam, Cholecalciferol
Chennai - 600 128
84. Atorvastatin A283 04/2024 03/2026 Rikenbik Pharma, Sample does not Drugs Testing
Tablets IP 10mg 113, SIDCO Industrial conform to IP Laboratory, Chennai -
Estate, Ambattur, Specification for 6
Chennai-600098. Atorvastatin
Calcium Tablets
with respect to
Dissolution.
Not of Standard Quality (NSQ) drugs:
The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.
(Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards
of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)
NOTE:
1. NSQ data was received as per Format & in EXCEL SHEET from State Drugs Licensing Authorities of Jammu Kashmir, Tamil
Nadu, Himachal Pradesh, Puducherry, Telangana, Thiruvananthapuram (Kerala), Tripura, Ladakh, Karnataka. Further NSQ
data was received from West Bengal, Goa as NIL. However, data was not received as per format in Excel Sheet from Assam
(PDF Format),Rajasthan (PDF Format), Jharkhand (PDF Format),Mizoram (PDF Format), for the Month of December, 2024
as per DCG(I) Circular dated 09.02.2024.
2. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Bihar, Chhattisgarh, Gujarat, Haryana, Manipur,
Meghalaya, Nagaland, Odisha, Punjab, Sikkim, Delhi, Uttarakhand, Andaman & Nicobar, Dadar and Nagar Haveli; Daman
and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of
December, 2024 as per DCG(I) Circular dated 09.02.2024.